Oral BCG vaccine in Crohn's disease.

W R Burnham, J E Lennard‐Jones, P Hecketsweiler, R Colín, Y Geffroy

Gut · 1979 · 42 citations · 11 references

DOIFull text

Open access

Concepts

Abstract

In a randomised double-blind trial over one year oral BCG has been compared with a control preparation in the treatment of chronic Crohn's disease. Overall assessment scores deteriorated in nine of 22 patients taking BCG, and 11 of 26 in the control group (P = 0.25); this deterioration was great enough to be regarded as a clinical relapse in three patients taking BCG and in seven taking the control preparation (P greater than 0.1). No significant benefit from oral BCG treatment has been demonstrated.

References

11